188 related articles for article (PubMed ID: 24140843)
1. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy.
Tollefson MK; Karnes RJ; Rangel L; Carlson R; Boorjian SA
J Urol; 2014 Mar; 191(3):646-51. PubMed ID: 24140843
[TBL] [Abstract][Full Text] [Related]
2. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
Heidenreich A; Varga Z; Von Knobloch R
J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
[TBL] [Abstract][Full Text] [Related]
3. Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006.
Musch M; Klevecka V; Roggenbuck U; Kroepfl D
J Urol; 2008 Mar; 179(3):923-8; discussion 928-9. PubMed ID: 18207170
[TBL] [Abstract][Full Text] [Related]
4. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for pelvic lymphoceles post-radical prostatectomy.
Khoder WY; Trottmann M; Buchner A; Stuber A; Hoffmann S; Stief CG; Becker AJ
Int J Urol; 2011 Sep; 18(9):638-43. PubMed ID: 21689165
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the morbidity between limited and extended pelvic lymphadenectomy during laparoscopic radical prostatectomy].
Rousseau B; Doucet L; Perrouin Verbe MA; Papin G; Erauso A; Joulin V; Deruelle C; Valeri A; Fournier G
Prog Urol; 2014 Feb; 24(2):114-20. PubMed ID: 24485081
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological prophylaxis of venous thromboembolism in contemporary radical retropubic prostatectomy: does concomitant pelvic lymphadenectomy matter?
Jessie BC; Marshall FF
Int J Urol; 2008 Oct; 15(11):951-6. PubMed ID: 18775031
[TBL] [Abstract][Full Text] [Related]
8. Extended vs standard pelvic lymphadenectomy during laparoscopic radical prostatectomy for intermediate- and high-risk prostate cancer.
Eden CG; Arora A; Rouse P
BJU Int; 2010 Aug; 106(4):537-42. PubMed ID: 20132202
[TBL] [Abstract][Full Text] [Related]
9. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.
Kawakami J; Meng MV; Sadetsky N; Latini DM; Duchane J; Carroll PR;
J Urol; 2006 Oct; 176(4 Pt 1):1382-6. PubMed ID: 16952638
[TBL] [Abstract][Full Text] [Related]
10. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
Arenas LF; Füllhase C; Boemans P; Fichtner J
Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
[TBL] [Abstract][Full Text] [Related]
11. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer.
Joslyn SA; Konety BR
Urology; 2006 Jul; 68(1):121-5. PubMed ID: 16806432
[TBL] [Abstract][Full Text] [Related]
12. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
Heidenreich A; Ohlmann CH
Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
[TBL] [Abstract][Full Text] [Related]
13. Incidence and risk factors of venous thromboembolism after pelvic uro-oncologic surgery--a single center experience.
Chen EC; Papa N; Lawrentschuk N; Bolton D; Sengupta S
BJU Int; 2016 Apr; 117 Suppl 4():50-3. PubMed ID: 26486818
[TBL] [Abstract][Full Text] [Related]
14. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: Assessing nodal yield, perioperative outcomes, and complications.
Zorn KC; Katz MH; Bernstein A; Shikanov SA; Brendler CB; Zagaja GP; Shalhav AL
Urology; 2009 Aug; 74(2):296-302. PubMed ID: 19515403
[TBL] [Abstract][Full Text] [Related]
15. How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications.
Capitanio U; Pellucchi F; Gallina A; Briganti A; Suardi N; Salonia A; Abdollah F; Di Trapani E; Jeldres C; Cestari A; Karakiewicz PI; Montorsi F
BJU Int; 2011 Apr; 107(7):1095-101. PubMed ID: 20880192
[TBL] [Abstract][Full Text] [Related]
16. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
[TBL] [Abstract][Full Text] [Related]
17. Limited pelvic lymph node dissection at the time of radical prostatectomy does not affect 5-year failure rates for low, intermediate and high risk prostate cancer: results from CaPSURE.
Berglund RK; Sadetsky N; DuChane J; Carroll PR; Klein EA
J Urol; 2007 Feb; 177(2):526-29; discussion 529-30. PubMed ID: 17222625
[TBL] [Abstract][Full Text] [Related]
18. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
Miyake H; Sakai I; Harada K; Hara I; Eto H
Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
[TBL] [Abstract][Full Text] [Related]
20. Pelvic lymph node dissection is associated with symptomatic venous thromboembolism risk during laparoscopic radical prostatectomy.
Eifler JB; Levinson AW; Hyndman ME; Trock BJ; Pavlovich CP
J Urol; 2011 May; 185(5):1661-5. PubMed ID: 21419428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
